Literature DB >> 22547169

Pharmacogenetics: Point-of-care genetic testing--a new frontier explored.

Paddy M Barrett, Eric J Topol.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22547169     DOI： 10.1038/nrcardio.2012.63

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  The unmet need of education in genomic medicine.

Authors:  Bradley A Patay; Eric J Topol
Journal:  Am J Med       Date:  2012-01       Impact factor: 4.965

2.  HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.

Authors:  Mark McCormack; Ana Alfirevic; Stephane Bourgeois; John J Farrell; Dalia Kasperavičiūtė; Mary Carrington; Graeme J Sills; Tony Marson; Xiaoming Jia; Paul I W de Bakker; Krishna Chinthapalli; Mariam Molokhia; Michael R Johnson; Gerard D O'Connor; Elijah Chaila; Saud Alhusaini; Kevin V Shianna; Rodney A Radtke; Erin L Heinzen; Nicole Walley; Massimo Pandolfo; Werner Pichler; B Kevin Park; Chantal Depondt; Sanjay M Sisodiya; David B Goldstein; Panos Deloukas; Norman Delanty; Gianpiero L Cavalleri; Munir Pirmohamed
Journal:  N Engl J Med       Date:  2011-03-24       Impact factor: 91.245

3.  Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.

Authors:  Nicoline J Breet; Jochem W van Werkum; Heleen J Bouman; Johannes C Kelder; Henk J T Ruven; Egbert T Bal; Vera H Deneer; Ankie M Harmsze; Jan A S van der Heyden; Benno J W M Rensing; Maarten J Suttorp; Christian M Hackeng; Jurriën M ten Berg
Journal:  JAMA       Date:  2010-02-24       Impact factor: 56.272

4.  Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.

Authors:  Jessica L Mega; Tabassome Simon; Jean-Philippe Collet; Jeffrey L Anderson; Elliott M Antman; Kevin Bliden; Christopher P Cannon; Nicolas Danchin; Betti Giusti; Paul Gurbel; Benjamin D Horne; Jean-Sebastian Hulot; Adnan Kastrati; Gilles Montalescot; Franz-Josef Neumann; Lei Shen; Dirk Sibbing; P Gabriel Steg; Dietmar Trenk; Stephen D Wiviott; Marc S Sabatine
Journal:  JAMA       Date:  2010-10-27       Impact factor: 56.272

Review 5.  CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis.

Authors:  Michael V Holmes; Pablo Perel; Tina Shah; Aroon D Hingorani; Juan P Casas
Journal:  JAMA       Date:  2011-12-28       Impact factor: 56.272

6.  Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.

Authors:  Pei Chen; Juei-Jueng Lin; Chin-Song Lu; Cheung-Ter Ong; Peiyuan F Hsieh; Chih-Chao Yang; Chih-Ta Tai; Shey-Lin Wu; Cheng-Hsien Lu; Yung-Chu Hsu; Hsiang-Yu Yu; Long-Sun Ro; Chung-Ta Lu; Chun-Che Chu; Jing-Jane Tsai; Yu-Hsiang Su; Sheng-Hsing Lan; Sheng-Feng Sung; Shu-Yi Lin; Hui-Ping Chuang; Li-Chen Huang; Ying-Ju Chen; Pei-Joung Tsai; Hung-Ting Liao; Yu-Hsuan Lin; Chien-Hsiun Chen; Wen-Hung Chung; Shuen-Iu Hung; Jer-Yuarn Wu; Chi-Feng Chang; Luke Chen; Yuan-Tsong Chen; Chen-Yang Shen
Journal:  N Engl J Med       Date:  2011-03-24       Impact factor: 91.245

7.  Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial.

Authors:  Jason D Roberts; George A Wells; Michel R Le May; Marino Labinaz; Chris Glover; Michael Froeschl; Alexander Dick; Jean-Francois Marquis; Edward O'Brien; Sandro Goncalves; Irena Druce; Alexandre Stewart; Michael H Gollob; Derek Y F So
Journal:  Lancet       Date:  2012-03-29       Impact factor: 79.321

8.  Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial.

Authors:  Matthew J Price; Dominick J Angiolillo; Paul S Teirstein; Elizabeth Lillie; Steven V Manoukian; Peter B Berger; Jean-François Tanguay; Christopher P Cannon; Eric J Topol
Journal:  Circulation       Date:  2011-08-29       Impact factor: 29.690

9.  Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

Authors:  Laurent Bonello; Udaya S Tantry; Rossella Marcucci; Ruediger Blindt; Dominick J Angiolillo; Richard Becker; Deepak L Bhatt; Marco Cattaneo; Jean Philippe Collet; Thomas Cuisset; Christian Gachet; Gilles Montalescot; Lisa K Jennings; Dean Kereiakes; Dirk Sibbing; Dietmar Trenk; Jochem W Van Werkum; Franck Paganelli; Matthew J Price; Ron Waksman; Paul A Gurbel
Journal:  J Am Coll Cardiol       Date:  2010-09-14       Impact factor: 24.094

10.  Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation.

Authors:  Matthew J Price; Sarah Endemann; Raghava R Gollapudi; Rafael Valencia; Curtiss T Stinis; Justin P Levisay; Alissa Ernst; Neil S Sawhney; Richard A Schatz; Paul S Teirstein
Journal:  Eur Heart J       Date:  2008-02-10       Impact factor: 29.983
  10 in total
  2 in total

Review 1.  Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?

Authors:  Mohamed H A Shahin; Julie A Johnson
Journal:  Curr Opin Cardiol       Date:  2013-05       Impact factor: 2.161

Review 2.  Inflammatory processes in cardiovascular disease: a route to targeted therapies.

Authors:  Neil Ruparelia; Joshua T Chai; Edward A Fisher; Robin P Choudhury
Journal:  Nat Rev Cardiol       Date:  2016-12-01       Impact factor: 32.419
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.